Clinical Trial Update: PGC-1 and Mitochondrial Dysfunction in Diabetes [NA]

View source ↗

Summary

A Mayo Clinic study investigating the role of PGC-1 and mitochondrial dysfunction in diabetes and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Snippet

Sponsor: Mayo Clinic | Conditions: Diabetes, Obese | NA | Status: COMPLETED